The Implementation of Antimicrobial Stewardship Using a Multidisciplinary Approach
Program Overview
Release Date: March 1, 2008 Expiration Date: February 28, 2009
Accreditation For Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1.0 hour (0.1 CEU) of continuing education credit (program number 204-000-07-466-H01P).
Methods/Format
This is an online activity consisting of audio, presentation slides, post-test, and activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is one hour. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of health-system pharmacy practitioners in academic, administrative, clinical, managed care, and supportive roles.
Activity Content
Click here to view an overview of the activity content.
Download Patient Case T.C.
Click here to view and print Patient Case T.C.
Learning Objectives
After participating in this educational activity, participants should be able to:
- Discuss the prevalence of type 2 diabetes and extent to which goals for glycemic control are achieved with currently available therapeutic approaches.
- Explain the role of incretins in postprandial glycemic control in healthy persons and the incretin abnormalities that contribute to type 2 diabetes.
- Describe the mechanisms of action, routes of administration, efficacy, and safety of currently available and investigational incretin analogs and DPP-4 enzyme inhibitors in patients with type 2 diabetes.
- Recommend appropriate use of an incretin analog or DPP-4 inhibitor in a patient with type 2 diabetes who is a suitable candidate for such therapy.
Faculty
Susan Cornell, B.S., Pharm.D., CDE, CDM
Assistant Director of Experiential Education
Assistant Professor
Department of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
John T. Johnson, Pharm.D., CDE
Clinical Associate Professor
The University of Georgia
College of Pharmacy
Athens, Georgia
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Susan Cornell, B.S., Pharm.D., CDE, CDM
Dr. Cornell declares that she has served as a speaker for Abbott, Bayer, Merck, LifeScan, Takeda, Novo-Nordisk, Omron, and Pfizer.
John T. Johnson, Pharm.D., CDE
Dr. Johnson declares that he has served as a consultant for GlaxoSmithKline and Novartis and as a speaker for Eli Lilly, DIN Network, and Pfizer.
Cathy C. Bowles, R.Ph. and Susan R. Dombrowski, M.S., R.Ph., program planners, declare that they have no relationships pertinent to this activity.
This activity is supported by an educational grant from Merck.
Launch Presentation
The Burden of Uncontrolled Type 2 DiabetesJohn T. Johnson, Pharm. D., CDE
A New Target in the Treatment of Type 2 Diabetes: The Incretin EffectSusan Cornell, B.S., Pharm.D., CDE, CDM
If you would prefer a podcast format of this activity, click here.
Download Post-Test
Click Here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage Testing Center and complete the test online.
